HIV Snippets – A Podcast Series: Optimizing Care in HIV Treatment and Prevention
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Click Here to Manage Email Alerts
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Activity Description
Antiretroviral therapy (ART) for treating HIV has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of 4 podcasts. The faculty will explore various aspects of HIV management, including geographic disparities in pre-exposure prophylaxis (PrEP) implementation, use of 3-drug versus 2-drug regimens, what is new in the HIV guidelines, as well as the management of treatment experienced patients with HIV.
Target Audience
The target audience for this activity is HIV specialists, infectious disease specialists, internists, pharmacists, nurse practitioners, physician associates, and other healthcare professionals involved in the management of patients with, or at risk for HIV.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Recognize geographic disparities that may hinder the implementation of preexposure prophylaxis for HIV in practice, as well as strategies that can overcome them.
- Review the latest evidence-based guidelines regarding the early detection and treatment of HIV infection in adults and adolescents and how they affect clinical decision-making.
- Recognize trends in the use of 2-drug regimens in the treatment of HIV.
- Incorporate best practices in the management of patients with HIV who are highly experienced with treatment.
Activity Chair
Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Investigator, Lundquist Institute
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA
Faculty
Latesha Elopre, MD, MSPH
Associate Professor
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL
Joseph J. Eron, Jr., MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC
Eileen Scully, MD, PhD
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Darcy Wooten, MD, MS
Associate Professor of Medicine
Division of Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, CA
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This program is acceptable for 1.0 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-23-019-H02-P, effective June 30, 2023. This is a knowledge-based activity, and there is no fee to attend.
This enduring material is approved for 1 year from the date of original release, June 30, 2023, to June 29, 2024.
How to Participate in This Activity and Obtain CE Credit
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, listen to the podcasts, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or Statement of Continuing Pharmacy Education Credit.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Eric S. Daar, MD
Consultant: Gilead, Merck, Theratechnologies, ViiV
Independent Research Contractor: Gilead, Merck, ViiV
Latesha Elopre, MD, MSPH
Independent Research Contractor: Merck
Joseph J. Eron, Jr., MD
Consultant: Gilead, Merck, ViiV
Independent Research Contractor (paid to institution): Gilead, ViiV
Eileen Scully, MD, PhD
No relevant financial relationships to disclose.
Darcy Wooten, MD, MS
No relevant financial relationships to disclose.
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. Text-based transcripts of these Podcasts are available upon request. Requests should include the Podcast title and can be emailed to cme@vindicoCME.com. Requests will be honored within 3-5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com